Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis

Human Pathology

Volumn 40, Issue 2, 2009, Pages 174-180

  Iguchi, Tomohiro ^a   Aishima, Shinichi ^a,b   Taketomi, Akinobu ^a   Nishihara, Yunosuke ^a   Fujita, Nobuhiro ^a   Sanefuji, Kensaku ^a   Sugimachi, Keishi ^a   Yamashita, Yo ichi ^a   Maehara, Yoshihiko ^a   Tsuneyoshi, Masazumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b HAMANOMACHI HOSPITAL   (Japan)

Author keywords

Carcinogenesis; Cholangiocarcinoma; Fascin

Indexed keywords

CYCLIN D1; FASCIN; MESSENGER RNA;

ADULT; ARTICLE; BILE DUCT CANCER; CARCINOGENESIS; DIAGNOSTIC PROCEDURE; DYSPLASIA; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTRAHEPATIC CHOLANGIOCARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL RATE; TUMOR BIOPSY; TUMOR VOLUME;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CARRIER PROTEINS; CHOLANGIOCARCINOMA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 58149134018     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2008.06.029     Document Type: Article

References (29)

1. Khan S.A., Thomas H.C., Davidson B.R., and Taylor-Robinson S.D. Cholangiocarcinoma. Lancet 366 (2005) 1303-1314
2. Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 33 (2001) 1353-1357
3. Anderson C.D., Pinson C.W., Berlin J., and Chari R.S. Diagnosis and treatment of cholangiocarcinoma. Oncologist 9 (2004) 43-57
4. Shimonishi T., Sasaki M., and Nakanuma Y. Precancerous lesions of intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 7 (2000) 542-550
5. Adams J.C. Roles of fascin in cell adhesion and motility. Curr Opin Cell Biol 16 (2004) 590-596
6. Hashimoto Y., Skacel M., and Adams J.C. Roles of fascin in human carcinoma motility and signaling: prospects for a novel biomarker?. Int J Biochem Cell Biol 37 (2005) 1787-1804
7. Kureishy N., Sapountzi V., Prag S., Anilkumar N., and Adams J.C. Fascins, and their roles in cell structure and function. Bioessays 24 (2002) 350-361
8. Anilkumar N., Annis D.S., Mosher D.F., and Adams J.C. Trimeric assembly of the C-terminal region of thrombospondin-1 or thrombospondin-2 is necessary for cell spreading and fascin spike organisation. J Cell Sci 1 (2002) 2357-2366
9. Hashimoto Y., Ito T., Inoue H., et al. Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma. Clin Cancer Res 11 (2005) 2597-2605
10. Zhang H., Xu L., Xiao D., et al. Fascin is a potential biomarker for early-stage oesophageal squamous cell carcinoma. J Clin Pathol 59 (2006) 958-964
11. Hashimoto Y., Shimada Y., Kawamura J., et al. The prognostic relevance of fascin expression in human gastric carcinoma. Oncology 67 (2004) 262-270
12. Hashimoto Y., Skacel M., Lavery I.C., Mukherjee A.L., Casey G., and Adams J.C. Prognostic significance of fascin expression in advanced colorectal cancer: an immunohistochemical study of colorectal adenomas and adenocarcinomas. BMC Cancer 6 (2006) 241
13. Pelosi G., Pastorino U., Pasini F., et al. Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer. Br J Cancer 88 (2003) 537-547
14. Pelosi G., Pasini F., Fraggetta F., et al. Independent value of fascin immunoreactivity for predicting lymph node metastases in typical and atypical pulmonary carcinoids. Lung Cancer 42 (2003) 203-213
15. Rodríguez-Pinilla S.M., Sarrió D., Honrado E., et al. Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas. Clin Cancer Res 12 (2006) 1533-1539
16. Yoder B.J., Tso E., Skacel M., et al. The expression of fascin, an actin-bundling motility protein, correlates with hormone receptor-negative breast cancer and a more aggressive clinical course. Clin Cancer Res 11 (2005) 186-192
17. Okada K., Shimura T., Asakawa K., et al. Fascin expression is correlated with tumor progression of extrahepatic bile duct cancer. HepatoGastroenterology 54 (2007) 17-21
18. Lee T.K., Poon R.T., Man K., et al. Fascin over-expression is associated with aggressiveness of oral squamous cell carcinoma. Cancer Lett 254 (2007) 308-315
19. Tong G.X., Yee H., Chiriboga L., et al. Fascin-1 expression in papillary and invasive urothelial carcinomas of the urinary bladder. Hum Pathol 36 (2005) 741-746
20. Yamaguchi H., Inoue T., Eguchi T., et al. Fascin overexpression in intraductal papillary mucinous neoplasms, adenomas, borderline neoplasms, and carcinomas) of the pancreas, correlated with increased histological grade. Mod Pathol. (2007) 1-10
21. Swierczynski S.L., Maitra A., Abraham S.C., et al. Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays. Hum Pathol 35 (2004) 357-366
22. Tetsu O., and McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398 (1999) 422-426
23. Sugimachi K., Aishima S., Taguchi K., et al. The role of overexpression and gene amplification of cyclin D1 in intrahepatic cholangiocarcinoma. J Hepatol 35 (2001) 74-79
24. Vignjevic D., Schoumacher M., Gavert N., et al. Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer. Cancer Res 67 (2007) 6844-6853
25. Jawhari A.U., Buda A., Jenkins M., et al. Fascin, an actin-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro. Am J Pathol 162 (2003) 69-80
26. Wong V., Ching D., McCrea P.D., and Firestone G.L. Glucocorticoid down-regulation of fascin protein expression is required for the steroid-induced formation of tight junctions and cell-cell interactions in rat mammary epithelial tumor cells. J Biol Chem 274 (1999) 5443-5453
27. Xie J.J., Xu L.Y., Zhang H.H., et al. Role of fascin in the proliferation and invasiveness of esophageal carcinoma cells. Biochem Biophys Res Commun 337 (2005) 355-362
28. Tao Y.S., Edwards R.A., Tubb B., Wang S., Bryan J., and McCrea P.D. Beta-catenin associates with the actin-bundling protein fascin in a noncadherin complex. J Cell Biol 134 (1996) 1271-1281
29. Sugimachi K., Taguchi K., Aishima S., et al. Altered expression of beta-catenin without genetic mutation in intrahepatic cholangiocarcinoma. Mod Pathol 14 (2001) 900-905